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Abstract
Background: A major benefit offered by telemedicine is the avoidance of travel, by patients, their carers and
health care professionals. Unfortunately, there is very little published information about the extent of avoided
travel. We propose to undertake a systematic review of literature which reports credible data on the reductions in
travel associated with the use of telemedicine.
Method: The conventional approach to quantitative synthesis of the results from multiple studies is to conduct a
meta analysis. However, too much heterogeneity exists between available studies to allow a meaningful meta
analysis of the avoided travel when telemedicine is used across all possible settings. We propose instead to
consider all credible evidence on avoided travel through telemedicine by fitting a linear model which takes into
account the relevant factors in the circumstances of the studies performed. We propose the use of stepwise
multiple regression to identify which factors are significant.
Discussion: Our proposed approach is illustrated by the example of teledermatology. In a preliminary review of
the literature we found 20 studies in which the percentage of avoided travel through telemedicine could be
inferred (a total of 5199 patients). The mean percentage avoided travel reported in the 12 store-and-forward
studies was 43%. In the 7 real-time studies and in a single study with a hybrid technique, 70% of the patients
avoided travel. A simplified model based on the modality of telemedicine employed (i.e. real-time or store and
forward) explained 29% of the variance. The use of store and forward teledermatology alone was associated with
43% of avoided travel. The increase in the proportion of patients who avoided travel (25%) when real-time
telemedicine was employed was significant (P = 0.014). Service planners can use this information to weigh up the
costs and benefits of the two approaches.
Background
Telemedicine can be defined as the use of information
and communications technology to provide health care
services for persons who are some distance from the
provider. Thus it is a technique, or process for service
delivery, which makes use of various technologies to
exchange information. A major benefit offered by tele-
medicine is the avoidance of travel, by patients, their
carers and health care professionals. Use of telemedicine
can reduce the cost and time of any travel required, and
lead to faster delivery of medical services. Avoided travel
is also an environmental benefit of telemedicine, and
one that is becoming increasingly important [1].
In designing a new telemedicine service, the planner
needs to know what avoided travel to expect. Clearly this
will depend on the types of patients and the specialties
involved. It is also likely to depend on the type of teleme-
dicine employed (i.e. real time or store and forward) and
a number of other factors. Unfortunately, only limited
information exists about the extent of savings that can be
expected for different telemedicine applications, and
there is very little published information about avoided
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travel savings through routine use of established teleme-
dicine applications in health care systems.
We therefore propose to undertake a systematic review
of literature which reports credible data on the reduc-
tions in travel associated with the use of telemedicine.
The intention is to summarise the information about the
proportion of avoidable travel possible through use of
different telemedicine applications in different contexts.
For the purposes of our study avoidable travel is defined
as the proportion of consultations or other episodes of
care using telemedicine in which patients, carers or
health professionals do not have to travel to another
centre.
Methods/Design
Review
The review will identify studies in which the percentage of
avoided travel or avoided referrals through use of teleme-
dicine was measured or inferred. This information will
then be used to make the best estimate possible of the
true value of the percentage travel avoided through use of
telemedicine in different medical specialties. Because tele-
medicine is often employed in very different ways within a
given speciality, it is necessary to take account of the rele-
vant factors. For example, telemedicine has been used in
cardiology for many years. However, there are obvious dif-
ferences between say the use of telecardiology to support
general practitioners and the use of telecardiology in pae-
diatric work. In the former, there may be store-and-for-
ward transmission of an ECG recorded in an adult patient
suspected of having a myocardial infarction; in the latter,
there may be real-time transmission of an echocardio-
graph from a new born baby suspected of a cardiac defect.
Thus for each “set of circumstances” (i.e. for each tele-
medicine application in a given specialty), the values that
are reported in the reviewed papers, or that can be derived
from the data that they include, can be considered as an
underlying true value plus an error component:
Yi = β0 + β1.Xi + εi
where Yi is the predicted value for avoided travel in a
given set of circumstances, i;
b0 is the baseline value (intercept);
bi is the coefficient relevant to the circumstances, Xi;
εi is the error term.
The error term may have both systematic and random
components. The question of defining the systematic
element is complex and not readily addressed [2]. We
propose to define the inclusion/exclusion criteria for
reported studies so that the mean systematic errors
associated with avoided travel can be ignored for the
purposes of our review.
Our original aim was to find studies where the effect
of using telemedicine on patient travel was explicitly
addressed, e.g. comparative studies in which patient
travel was reported for a telemedicine arm and for a
control arm. However, a preliminary review showed
that there were very few studies where this had been
done. Therefore we intend widening the scope to
include non-comparative studies which report the per-
centage of patients in a telemedicine group who avoid
travel. The subtle difference here is that we know that
in any usual care group, a proportion of such patients
could avoid travel. That is, in some patients who pre-
sent at an outpatient clinic, for example, in the ordin-
ary way, there will be some who will have been
referred inappropriately, see Figure 1. To reduce the
risk of bias in the selected studies influencing our esti-
mates of avoided travel, we will assess reliability of
data, study performance and sample size. Scores from
our assessments of these factors will be used to calcu-
l a t eaw e i g h t i n gf a c t o r .
Literature search strategy
Computerized literature searches will be performed
using MEDLINE, HealthSTAR, EMBASE, CINAHL and
the Cochrane Database of Systematic Reviews, with no
date restrictions. The search strategy will make use of
both controlled vocabulary, such as the National Library
of Medicine’s MeSH (Medical Subject Headings), and
appropriate keywords.
Two approaches are possible. In the first, the search
terms focus on the concepts of travel savings or avoided
referrals through the use of telemedicine generally:
(phrase A) AND (phrase B) AND (phrase C)
where
phrase A = Telemedicine OR Telehealth OR telecare
OR teleconsultation
phrase B = Avoid* OR prevent* OR decrease OR
reduce OR unnecessar* OR sav* OR prevent
phrase C = Travel OR referral OR visit OR admis-
sion OR hospitalization OR transfer* OR transport*
OR cost saving* OR appointment OR cost stud* OR
remote consultation* OR economic*
In the second, the search terms focus on telemedicine
and its use in specific specialties:
(phrase A) AND (phrase D)
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phrase D = Dermatology (for example)
In addition, telemedicine journals will be hand
searched to identify any further relevant publications.
Grey literature (i.e. literature that is not commercially
published) will be identified by searching the websites of
health technology assessment and related agencies, and
professional associations.
Selection criteria
The inclusion criteria will be:
(1) publications that consider travel or travel-related
issues for patients, carers or health professionals, and
include appropriate details on the data, methods of
analysis and outcomes applicable to avoidance of
travel. The proportion of avoided travel will be
reported directly, or be easily calculable using the
information in the paper;
(2) publications reporting studies in which at least
15 patients were managed using telemedicine;
(3) publications that contain an electronic abstract;
(4) publications in the English language.
The exclusion criteria will be:
(1) any paper not reporting the sample size or metho-
dology for calculating the percentage of avoided travel;
(2) articles where only anecdotal information on tra-
vel-related issues is given, without credible data and
analysis;
(3) single case studies and series with fewer than 15
individuals;
(4) duplicate publications.
Figure 1 Example of avoided travel. The data represent the results of a hypothetical study in which 100 patients were seen by a
dermatologist in hospital, and 100 patients were seen by a dermatologist using telemedicine. In both groups, 5% of the patients were
considered to have been referred inappropriately (e.g. because the underlying skin problem had resolved by the time they were seen by the
specialist). In the telemedicine group, 60 of the patients were managed successfully by telemedicine but 35 still required a conventional
appointment. The effect of telemedicine could be considered as avoiding travel for 60% of those in the telemedicine group, although it could
also be argued that the proportion was slightly higher (60 out of 95 appropriate referrals).
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At least two reviewers will independently apply the
selection criteria to the titles and abstracts returned by
the literature search. Full-text articles will be obtained
for abstracts that meet the selection criteria and for
undecided articles. Articles will be perused and included
for review if they meet the selection criteria. Any discre-
pancies between reviewers’ decisions will be resolved by
consensus. At least two reviewers will independently
extract data from the selected publications using a data
abstraction form, created ap r i o r i . Any disagreements
will be resolved by consensus.
Information extracted will include the medical specialty;
setting and duration of study; patient numbers and charac-
teristics; details of data related to avoidance of travel
through use of telemedicine; telemedicine modality.
Assessment of risk of bias
Each study will be assigned to one of three classes
related to the reliability of data:
(1) studies in which data on avoidance of travel or
referrals through use of telemedicine were collected
prospectively (score 3);
(2) prospective studies in which estimates of travel
or referrals avoided through use of telemedicine
were based on the opinions of the investigators
(score 2);
(3) retrospective or hypothetical studies (i.e. “thought”
experiments), including appraisal of patient records
(score 1).
These scores reflect differences in strength of evidence
between prospective and retrospective studies, and
between prospective collection of data and estimates
based on expert opinion.
In assessing study performance, four areas will be
considered:
(1) subjects: how recruited to the study;
(2) intervention: adequate description of the inter-
vention used for the treatment of patients;
(3) data analysis: details of how the data were col-
lected and analysed;
(4) outcomes: inclusion of individual subject data or
a statistical summary, details of missing results, drop
outs.
For each of these items, there will be an expectation
of reasonable quality data and clear presentation of
details. If all these areas are adequately covered, study
performance can be regarded as good quality (score 3).
If there are limitations or omissions in one of the items,
the study performance is fair (score 2). Limitations in
more than one item would indicate poor performance
quality (score 1).
The sample size will be taken as the number in the
telemedicine intervention group. The sample size will be
categorized as:
(1) large, i.e. ≥150 (score 3);
(2) medium, i.e. 50-149, (score 2);
(3) small, i.e. 15-49 (score 1).
For the purposes of our analysis each of the indices
(study design, study performance and sample size) will
be regarded as equally important. For each study, the
scores for each index (3, 2 or 1) will be summed to give
an individual study weighting factor with a minimum of
3 and a maximum of 9 (i.e. a 7-point scale).
At least two reviewers will determine scores for study
design, study performance and sample size for each
study. Any disagreements will be resolved by consensus.
Data synthesis
We expect that the number of publications dealing
explicitly with travel savings through use of telemedicine
will be small. We therefore propose a methodology that
will take into account all the credible evidence, even
some that is weak, rather than attempting to analyse
effect size on a restricted dataset of the more rigorous
studies.
The conventional approach to quantitative synthesis of
the results from multiple studies is to conduct a meta-
analysis. However, there are well known difficulties
about attempting to combine results from studies which
are too dissimilar [3]. Our hypothesis is that far too
much heterogeneity exists between available studies to
allow a meaningful meta-analysis of the data on avoided
travel when telemedicine is used across all possible set-
tings. There is also a dearth of randomized controlled
trials in telemedicine. It follows that a different
approach is required.
We propose instead to consider all credible evidence
on avoided travel through telemedicine, and to fit a lin-
ear model which takes into account the relevant factors
in the circumstances of the studies performed. We pro-
pose the use of stepwise multiple regression to identify
which factors are significant. Possible factors are listed
in Table 1.
In accordance with the MOOSE recommendations
for reporting the results of meta-analyses of observa-
tional studies, we will include graphical summaries of
study estimates and any combined estimate, a table
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of sensitivity testing and any subgroup analysis, and
an indication of the statistical uncertainty of findings
[4].
The process of data synthesis is thus:
(1) study selection following the literature search;
(2) data extraction, including calculation of study
weighting factors;
(3) regression analysis.
Example
The methodology above is illustrated by the example of
teledermatology. A preliminary review of the literature
(April 2010) found 20 studies in which the percentage
of avoided travel through telemedicine could be inferred
(see Table 2). The total number of patients in these stu-
dies was 5199. The mean percentage avoided travel in
the 12 store-and-forward studies was 43%. The mean
proportion of patients who avoided travel in the 7 real-
time studies and in a single study using a hybrid techni-
que was 70%, see Figure 2.
Dummy coding can be used to represent putative pre-
dictive variables as follows:
Modality - baseline (store and forward); hybrid; real-
time
Country - baseline (North America); Europe; Rest of
world
Patient group - baseline (all ages); only adults; only
children
A linear model with all three putative predictors fits
the data well (R
2 = 0.761). However, the coefficients for
country and for patient group are not significant. Sim-
plifying the model to include only the significant predic-
tor Modality produces R
2 = 0.292. It also shows that the
coefficients for Hybrid and for Real-time are almost
identical in size. If the single study in which a hybrid
technique was used [5] is reclassified as real-time, then
the model (R
2 = 0.291) is:
A = 42.8 + 24.5.M
where A is percentage of avoided travel;
M = 0 if store-and-forward is used and M = 1 if
real-time telemedicine is used.
That is, use of store and forward teledermatology was
associated with avoided travel for a mean of 43% of the
patients in the studies (P < 0.001). The improvement in
the proportion of patients who avoided travel (25%)
when real-time telemedicine was employed is significant
(P = 0.014), Table 3.
Discussion
Our proposed review is intended as an appraisal of the
travel savings achievable through telemedicine. Our
methodology takes a relatively simple approach to the
assessment of studies, and makes a number of assump-
tions. For example, the decision to allocate equal
weights to reliability of data, study performance and
sample size is arbitrary. An earlier approach to quality
assessment of telemedicine studies used differential
weights, with the weight for study performance being
twice that for study design [6]. It would also be possible
to classify both reliability of data and study performance
Table 1 Factors which may influence the avoided travel
resulting from a particular telemedicine application
Modality Store and forward
Hybrid
Real time
Setting - referral source Home
Primary care
Hospital
Setting - referral location Metropolitan
Rural
Travel distance or travel time Long (> = 1 hour)
Short (< 1 hour)
Patient age Young (fetal and paediatric)
Adult
Elderly
Urgency Elective
Emergency
Purpose Diagnosis
Management (treatment, monitoring)
Health system Private
Public
Specialty Cardiology
Dermatology
Psychiatry
etc (see Table 4)
Wootton et al. BMC Health Services Research 2011, 11:185
http://www.biomedcentral.com/1472-6963/11/185
Page 5 of 10Table 2 Data for 20 teledermatology studies in which travel avoided was estimated
Author Year Percentage of
patients who
avoided travel
Study
design (a)
Sample
size
Weight (b) Country Modality (c) Urgency Referral setting Patient age Comment
Whited J
[10]
2002 18.5 3 135 8 USA S/F Elective Primary care Mean 61 years (SD 13.8)
Bowns I
[11]
2006 42.4 3 92 8 UK S/F Elective Primary care 16 years and over Excludes children
White H
[12]
1999 25.0 2 40 4 UK S/F Elective Primary care Not stated
Loane M
[13]
2000 31.3 3 96 8 UK S/F Elective Primary care 7 months to 81 years Loane 2000 is two arms of the
same study
Taylor P
[14]
2001 31.4 2 376 8 UK S/F Elective Hospital OPD
clinic
Not stated 376 tele-assessments; 194
patients
Knol A [15] 2006 51.4 2 306 8 Netherlands S/F Elective Primary care 0-96 years (in larger sample of
505 patients)
Wootton R
[16]
2000 53.9 3 102 8 UK R/T Elective Primary care 4 months to 89 years (in larger
sample of 204 patients)
Loane M
[13]
2000 55.2 3 96 8 UK R/T Elective Primary care 7 months to 81 years Loane 2000 is two arms of the
same study
Lamminen
H [17]
2000 72.0 2 25 7 Finland R/T Elective Primary care Mean 45 years (range 4-92)
Granlund
H [18]
2003 81.3 1 16 4 Finland R/T Elective Primary care Mean 40 years (SD 21), both
groups
70% of 23 patients in video
group said they had not visited
hospital at 6-month follow-up
Chen T
[19]
2010 94.0 1 429 6 USA S/F Elective Primary care Mean 5.9 years (range 0-12
years 11 months)
Only children (12 years or
younger)
Romero G
[5]
2009 70.0 3 368 9 Spain Hybrid Elective Primary care Mean 36 years (range 2
months -86 years) [but this
includes an extra control
group]
192 pts had S/F alone; 176 had
S/F and then Real-time
Eminovic N
[20]
2009 39.0 3 200 9 Netherlands S/F Elective Primary care Mean approx 43 years
Moreno-
Ramirez D
[21]
2007 51.2 2 2009 8 Spain S/F ?Urgent Primary care Mean 41.5 years Pigmented skin lesions –
possible skin cancer
Klaz I [22] 2005 77.9 2 435 7 Israel S/F Elective Primary care Mean 22.4 years (range 18-39) Excludes children
Eminovic N
[23]
2003 22.9 2 96 7 Netherlands S/F Elective Primary care Mean 35 years Patients provided the images
Oakley A
[24]
2000 88.0 2 109 6 New
Zealand
R/T Elective Primary care Mean 41 years (range 1 month
to 94 years) [may include non-
telederm patients as well)
Burgiss S
[25]
1997 92.0 1 87 4 USA R/T Elective Primary care Not stated
Gilmour E
[26]
1998 50.8 3 61 8 UK R/T Elective Primary care 3 months to 83 years (for all
126 patients)
Jemec G
[27]
2008 27.3 1 121 4 Denmark
(Faroes)
S/F Elective Primary care Mean 37 years (SD 20)
(a) 1 = prospective; 2 = estimated; 3 = retrospective (see text)
(b) score 3-9 (see text)
(c) S/F, store-and-forward; R/T, real-time
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0in more detail [6,7]. These are matters that might be
considered in future studies.
The use of stepwise regression to identify significant
factors has been used previously in meta-regression
[8,9]. Because of the relatively small dataset in the der-
matology example (n = 20), it was not possible to
explore the significance of all possible factors. How-
ever, the model appeared to produce sensible results
when three factors were investigated. With a large
dataset, such as that likely to result from the proposed
systematic review, it would be possible to explore most
or all of the possible factors in Table 1 and to do so
using a robust exploration technique, such as
resampling.
Some matters may need to be developed further after
the review commences. One of these is how the studies
will be classified in terms of the medical specialties
involved, since there does not appear to be an interna-
tionally-accepted system for classification. Our proposal,
ap r a g m a t i cs c h e m e ,i ss h o wn in Table 4. The signifi-
cance of other factors, such as study setting and urgency
of consultations is unclear at this stage and will need to
be explored after more data become available.
Numbers of studies in some specialties may be small
and will therefore provide estimates of travel savings
which have a high level of uncertainty. Nevertheless, such
results are expected to provide helpful initial indications
and should assist in defining areas for future work.
The example analysis of dermatology studies suggests
that substantial avoided patient travel can be expected
through the use of store-and-forward telemedicine. The
results also provide an estimate of the additional value
of real-time telemedicine, a technique which is generally
speaking less convenient and more expensive than
store-and-forward telemedicine. Service planners can
use this information to weigh up the costs and benefits
of the two approaches. A systematic review across the
whole of telemedicine with data synthesis in accordance
with the proposals in the present paper therefore
appears likely to provide important information for
those planning the future introduction of telemedicine
services around the world.
Figure 2 Avoided referrals from primary care. Avoided referrals as a result of the use of teledermatology in referrals from primary care (20
studies from 1997-2010). The areas of the symbols are proportional to the study weights. The broken lines represent the avoided travel
expected from the fitted model (see text).
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Page 7 of 10Table 3 Coefficients of fitted model (using Modality as a predictor)
Unstandardized coefficients Standardized coefficient
B SE Beta t P-value
(Baseline) 42.816 5.616 7.6 < 0.001
Dummy_modality2 24.487 9.011 0.539 2.7 0.014
Table 4 Categories of specialties
Specialty Subspecialty ... Specialty ... Subspecialty
Allied Health Pathology
Chiropractice Anatomical
Occupational therapy Bacteriology
Physiotherapy Breast cancer
Podiatry Clinical chemistry
Rehabilitation Cytopathology
Speech therapy Dermatology
Anaesthesia Forensic
Intensive care Haematology
Obstetric Histology
Pain Immunology
Emergency medicine Microbiology
Neuropathology
General practice Public Health
Environmental
Internal Medicine Occupational
Cardiology Preventive
Dermatology Radiology
Endocrinology Diagnostic
Gastroenterology Neuroradiology
Genetics Nuclear medicine
Geriatrics Oncology
Haematology Radiography
Hepatology Radiotherapy
Immunology Ultrasound
Infectious diseases Surgery
Intensive care Abdominal
Maternal/fetal Burns
Neurology Colon/Rectal
Oncology ENT
Ophthalmology Hand
Preventive Head and neck
Renal Maxillo-Facial
Reproductive Neurosurgery
Respiratory Oncology
Rheumatology Ophthalmology
Sexual and reproductive health Orthopaedics
Thoracic Plastic
Tropical diseases Spinal
Tropical medicine Thoracic
Mental Health Urology
Psychiatry Vascular
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